Riskpilot← Back to searchSign inGet full accessMEDEASY AS
ASActiveOrg 926650920Teglverksveien 42, 4632 Kristiansand SOther education n.e.c. · NACE 8559Est. 20210 employees
Revenue 2024
NOK 20,3M
+8% vs 2023
EBITDA margin
0.9%
-68% vs 2023
Equity ratio
5.1%
Financial strength
Net profit 2024
NOK 134K
-75% vs 2023
| Revenue | NOK 20,3M | +8% |
| EBITDA | NOK 186K | -68% |
| Net profit | NOK 134K | -75% |
| Total assets | NOK 5,2M | +16% |
| Equity | NOK 265K | +102% |
| Employees | 0 | — |
Legal name
MEDEASY AS
Org number
926650920
Legal form
Aksjeselskap
NACE code
8559 · Other education n.e.c.
Founded
22. februar 2021
Share capital
NOK 30 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg. Styrets leder alene.
Company purpose
Salg og markedsføring av digital undervisningstjeneste for helsefagstudenter, individuell veiledning av studentene, samt annen virksomhet som står i naturlig tilknytning til dette.
Address
Teglverksveien 42, 4632 Kristiansand S
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 0 | 13 787 | 18 903 | 20 347 |
| Staff expenses | −0 | −0 | −0 | −0 |
| EBITDA | −11 | −388 | 575 | 186 |
| Depreciation & amort. | −8 | −8 | −18 | −14 |
| EBIT | −19 | −397 | 557 | 172 |
| Net financials | 0 | −0 | 0 | −1 |
| Profit before tax | −19 | −397 | 557 | 172 |
| Tax | −7 | 7 | 29 | 38 |
| Net profit | −12 | −403 | 528 | 134 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 61 | 1 588 | 4 486 | 5 201 |
| Equity | 7 | −397 | 131 | 265 |
| Long-term debt | 0 | 0 | 0 | 2 |
| Short-term debt | 55 | 1 985 | 4 355 | 4 934 |
| Total debt | 55 | 1 985 | 4 355 | 4 936 |
EBITDA margin
0.9%
This company
15.8%
Market median
-94% vs market
20212024
Equity ratio
5.1%
This company
38.2%
Market median
-87% vs market
20212024
Return on equity
50.6%
This company
18.4%
Market median
+175% vs market
20212024
Net profit margin
0.7%
This company
8.1%
Market median
-91% vs market
20212024
Asset turnover
3.91×
This company
1.12×
Market median
+249% vs market
20212024
Debt / equity
18.64×
This company
0.62×
Market median
-2906% vs market
20212024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-18 – 2021-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2024 | — | — | |
| Chairman | 2025 | — | — | |
| Board of Directors | 2025 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Medeasy Group As | Company | 100.0% | 100.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Holmen Innovative Solutions As
MEDEASY AS Board members of MEDEASY AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nikolai Fredrik Tallaksen Ulseth | Board of Directors | 0 companies |
| Elisabeth Tallaksen Ulseth | Board of Directors | 0 companies |
| Christian Fredrik Stray | Chairman | 0 companies |
| Sigve Holmen | Chairman | 0 companies |
| Nils Christian Tvedt Karlsen | Board of Directors | 0 companies |